Spots Global Cancer Trial Database for postmenopausal women with advanced breast cancer
Every month we try and update this database with for postmenopausal women with advanced breast cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment | NCT00237198 | Postmenopausal ... | Letrozole | 20 Years - 79 Years | Novartis | |
| Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer | NCT00237211 | Postmenopausal ... | Letrozole | 20 Years - 74 Years | Novartis | |
| Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer | NCT00247663 | Postmenopausal ... | Letrozole | 20 Years - 74 Years | Novartis | |
| Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer | NCT00247663 | Postmenopausal ... | Letrozole | 20 Years - 74 Years | Novartis | |
| Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment | NCT00237198 | Postmenopausal ... | Letrozole | 20 Years - 79 Years | Novartis |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
